← Leaderboards
Jonathan Ozik
Loyola University Chicago
$2,212,458
Attributed
$7,826,433
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,826,433 · 3
By mechanism
R01$7,826,433 · 3
Top collaborators
- Basmattee Boodram9 shared
- Harel Dahari9 shared
- Karen Patricia Day6 shared
- Kwadwo Ansah Koram6 shared
- Mercedes Pascual6 shared
- Abraham Rexford Oduro5 shared
- Abraham Rexford Oduro1 shared
Most similar at Loyola University Chicago
Same institution · by research overlap
- Susan L Uprichard$8,275,018
- Basmattee Boodram$4,816,495
- Harel Dahari$6,227,500
- Timothy Spear$153,954
- Liang Qiao$4,617,387
Others in their field
Other Emerging Leaders on “Transmission Process”
- Scott Hensley · University Of Pennsylvania$49,758,212
- Thomas Denny · Duke University$22,999,550
- S. Mark Tompkins · University Of Georgia$20,806,329
- Walter Orenstein · Emory University$15,988,348
- Andrew Pekosz · Johns Hopkins University$15,027,681
- Esther M. Friedman · University Of Michigan At Ann Arbor$10,105,179
Research focus
Transmission ProcessPathogenInfectionComplexComputer ModelsBaseEpidemiologic DataAreaGlobal HealthHepatitis C TransmissionDrug UsageHepatitis C IncidenceIncidenceBehavioralHarm ReductionDesignIllinoisCommunitiesChicagoClinical TrialsGeographic FactorGeographyCaringDiagnosis
Grant awards (15)
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions$678,903
R01 · FY2025 · AI
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions$695,569
R01 · FY2024 · AI
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions$708,050
R01 · FY2023 · AI
Temporal strain structure and response to interventions in a high endemicity region of Plasmodium falciparum$519,224
R01 · FY2023 · AI
Temporal strain structure and response to interventions in a high endemicity region of Plasmodium falciparum$1
R01 · FY2023 · AI
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions$759,667
R01 · FY2022 · AI
Temporal strain structure and response to interventions in a high endemicity region of Plasmodium falciparum$574,059
R01 · FY2022 · AI
Temporal strain structure and response to interventions in a high endemicity region of Plasmodium falciparum$603,968
R01 · FY2021 · AI
Computational discovery of effective hepatitis C intervention strategies$398,579
R01 · FY2021 · GM
Temporal strain structure and response to interventions in a high endemicity region of Plasmodium falciparum$612,795
R01 · FY2020 · AI
Computational discovery of effective hepatitis C intervention strategies$397,172
R01 · FY2020 · GM
Temporal strain structure and response to interventions in a high endemicity region of Plasmodium falciparum$662,598
R01 · FY2019 · AI
Computational discovery of effective hepatitis C intervention strategies$395,551
R01 · FY2019 · GM
Computational discovery of effective hepatitis C intervention strategies$397,037
R01 · FY2018 · GM
Computational discovery of effective hepatitis C intervention strategies$423,260
R01 · FY2017 · GM